Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology

被引:27
|
作者
Zehbe, Ingeborg [1 ,2 ,3 ]
Jackson, Robert [1 ,4 ]
Wood, Brianne [5 ]
Weaver, Bruce [3 ]
Escott, Nicholas [3 ,6 ]
Severini, Alberto [7 ]
Krajden, Mel [8 ]
Bishop, Lisa [2 ]
Morrisseau, Kyla [2 ]
Ogilvie, Gina [8 ,9 ]
Burchell, Ann N. [10 ,11 ]
Little, Julian [5 ]
机构
[1] Thunder Bay Reg Res Inst, Probe Dev & Biomarker Explorat, Thunder Bay, ON, Canada
[2] Lakehead Univ, Dept Biol, Thunder Bay, ON, Canada
[3] Northern Ontario Sch Med, Clin Sci, Thunder Bay, ON, Canada
[4] Lakehead Univ, Biotechnol Program, Thunder Bay, ON, Canada
[5] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada
[6] Thunder Bay Reg Hlth Sci Ctr, Dept Pathol & Lab Med, Thunder Bay, ON, Canada
[7] Publ Hlth Agcy Canada, Viral Exanthemata & STD Sect, Natl Microbiol Lab, Winnipeg, MB, Canada
[8] BC Ctr Dis Control, Vancouver, BC, Canada
[9] Univ British Columbia, Sch Populat & Publ Hlth, Fac Med, Vancouver, BC, Canada
[10] Ontario HIV Treatment Network, Toronto, ON, Canada
[11] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
来源
BMJ OPEN | 2016年 / 6卷 / 10期
基金
加拿大健康研究院;
关键词
TO-TREAT ANALYSIS; 1ST NATIONS; NEW-ZEALAND; WOMEN; HPV; STATEMENT; CANADA; INTERVENTION; INDIVIDUALS; AUSTRALIA;
D O I
10.1136/bmjopen-2016-011754
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The incidence of cervical cancer is up to 20-fold higher among First Nations women in Canada than the general population, probably due to lower participation in screening. Offering human papillomavirus (HPV) self-sampling in place of Papanicolaou (Pap) testing may eventually increase screening participation and reduce cervical cancer rates in this population. Design: A community-randomised controlled screening trial. Setting: First Nations communities in Northwest Ontario, Canada. Participants: Women aged between 25 and 69, living in Robinson Superior Treaty First Nations. The community was the unit of randomisation. Interventions: Women were asked to complete a questionnaire and have screening by HPV self-sampling (arm A) or Pap testing (arm B). Primary outcome measures: The number of women who participated in cervical screening. Randomisation: Community clusters were randomised to include approximately equivalent numbers of women in each arm. Results: 6 communities were randomised to arm A and 5 to arm B. One community withdrew, leaving 5 communities in each group (834 eligible women). Participation was <25%. Using clustered intention-to-treat (ITT) analysis, initial and cumulative averaged uptakes in arm A were 1.4-fold (20% vs 14.3%, p=0.628) and 1.3-fold (20.6% vs 16%, p=0.694) higher compared to arm B, respectively. Corresponding per protocol (PP) analysis indicates 2.2-fold (22.9% vs 10.6%, p=0.305) and 1.6-fold (22.9% vs 14.1%, p=0.448) higher uptakes in arm A compared to arm B. Screening uptake varied between communities (range 0-62.1%). Among women who completed a questionnaire (18.3% in arm A, 21.7% in arm B), the screening uptake was 1.8-fold (ITT; p=0.1132) or 3-fold (PP; p<0.01) higher in arm A versus arm B. Conclusions: Pap and HPV self-sampling were compared in a marginalised, Canadian population. Results indicated a preference for self-sampling. More research on how to reach underscreened Indigenous women is necessary.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics
    Dannecker, C
    Siebert, U
    Thaler, CJ
    Kiermeir, D
    Hepp, H
    Hillemanns, P
    ANNALS OF ONCOLOGY, 2004, 15 (06) : 863 - 869
  • [32] Self-sampling for human papillomavirus (HPV) testing as cervical cancer screening option.: Experience from the LAMS Study
    Longatto-Filho, A.
    Roteli-Martins, C.
    Hammes, L.
    Etlinger, D.
    Pereira, S. M. Miranda
    Erzen, M.
    Branca, M.
    Naud, P.
    Derchain, S. F. M.
    Sarian, L. O.
    Matos, J.
    Gontijo, R.
    Lima, T.
    Maeda, M. Y. S.
    Tatti, S.
    Syrjanen, S.
    Syrjanen, K.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2008, 29 (04) : 327 - 332
  • [33] The potential role of self-sampling for high-risk human papillomavirus detection in cervical cancer screening
    Schmeink, Channa E.
    Bekkers, Ruud L. M.
    Massuger, Leon F. A. G.
    Melchers, Willem J. G.
    REVIEWS IN MEDICAL VIROLOGY, 2011, 21 (03) : 139 - 153
  • [34] Vaginal Self-Sampling for Human Papillomavirus Infection as a Primary Cervical Cancer Screening Tool in a Haitian Population
    Boggan, Joel C.
    Walmer, David K.
    Henderson, Gregory
    Chakhtoura, Nahida
    McCarthy, Schatzi H.
    Beauvais, Harry J.
    Smith, Jennifer S.
    SEXUALLY TRANSMITTED DISEASES, 2015, 42 (11) : 655 - 659
  • [35] Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among unand under-screened Maori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening
    Brewer, Naomi
    Bartholomew, Karen
    Maxwell, Anna
    Grant, Jane
    Wihongi, Helen
    Bromhead, Collette
    Scott, Nina
    Crengle, Sue
    Cunningham, Chris
    Douwes, Jeroen
    Potter, John D.
    BMC CANCER, 2019, 19 (01)
  • [36] COST-EFFECTIVENESS ANALYSIS OF CERVICAL CANCER SCREENING WITH SELF-SAMPLING FOR HUMAN PAPILLOMAVIRUS (HPV) TESTING IN TAIWAN
    Tsai, B. C.
    Chow, I. H. I.
    Liao, C. H.
    You, S. L.
    Tang, C. H.
    Pwu, R. F.
    VALUE IN HEALTH, 2012, 15 (07) : A656 - A657
  • [37] Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening
    Naomi Brewer
    Karen Bartholomew
    Anna Maxwell
    Jane Grant
    Helen Wihongi
    Collette Bromhead
    Nina Scott
    Sue Crengle
    Chris Cunningham
    Jeroen Douwes
    John D. Potter
    BMC Cancer, 19
  • [38] Economic Evaluation of Mailed Home-Based Human Papillomavirus Self-sampling Kits for Cervical Cancer Screening
    Meenan, Richard T.
    Troja, Catherine
    Buist, Diana S. M.
    Tiro, Jasmin A.
    Lin, John
    Anderson, Melissa L.
    Gao, Hongyuan
    Green, Beverly B.
    Winer, Rachel L.
    JAMA NETWORK OPEN, 2023, 6 (03) : E234052
  • [39] Comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in France
    Laura Reques
    Camille Rolland
    Anne Lallemand
    Najat Lahmidi
    Ezequiel Aranda-Fernández
    Antonio Lazzarino
    Julie Bottero
    Françoise Hamers
    Christine Bergeron
    Ken Haguenoer
    Guy Launoy
    Niklas Luhmann
    BMC Women's Health, 21
  • [40] Comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in France
    Reques, Laura
    Rolland, Camille
    Lallemand, Anne
    Lahmidi, Najat
    Aranda-Fernandez, Ezequiel
    Lazzarino, Antonio
    Bottero, Julie
    Hamers, Francoise
    Bergeron, Christine
    Haguenoer, Ken
    Launoy, Guy
    Luhmann, Niklas
    BMC WOMENS HEALTH, 2021, 21 (01)